investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Polysomy 21 in Acute Lymphoblastic Leukemia
David Marc Weinstock
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
David Marc Weinstock
Dana-Farber Cancer Institute
Boston, United States
Related projects
James Y. Chen
Clonal Evolution and Prospective Isolation of Myelodysplastic Syndrome Initiating
Leukaemia
Tomasz Skorski
BCR/ABL-PI-3k-ROS pathway induce genomic instability ....
Leukaemia
Pathology
Hematology and hematologic malignancies
Jon C Aster
Oncogenic Notch Signaling
Leukaemia
Pathology
Hematology and hematologic malignancies
Scott Moore Carlson
The role of PRDM1 in epigenetic regulation and tumor suppression
Leukaemia
Scott H Kaufmann
Regulation of Death Ligand-Induced Killing
Leukaemia
Pathology
Hematology and hematologic malignancies
Ashley Marie Pandolfi
Unraveling crucial roles of homeobox gene Hlx in hematopoiesis and leukemogenesis
Leukaemia
Hematology and hematologic malignancies
Daniel McVicar
Characterization of the Expression and Ligands of KIR3DS2
Leukaemia
Pathology
Hematology and hematologic malignancies
Catherine Ju-Ying Wu
Personal tumor neoantigens for immunity against chronic lymphocytic leukemia
Leukaemia
Craig B Thompson
Role of IDH Mutations in Acute Myeloid Malignancies
Leukaemia